{'en': 'Novalab company sold to Air Liquide Healthcare', 'es': 'Empresa Novalab vendida a Air Liquide Healthcare'} Image

Novalab company sold to Air Liquide Healthcare

fer's profile photo   07/14/2016 11:35 a.m.

Air Liquide Healthcare, leading company of the house of home respiratory therapies in Spain, successfully closed on July 4 the agreement acquired by Novalab Iberian, specialized in advanced products and services for diabetes.

In this way Air Liquide enters the diabetes market, mainly with solutions for insulin-dependent patients and continuous glucose monitoring systems, since it has incorporated into the third most important company in the sector with an important patient base, a positionRelevant in the market and a very focused business towards this sector, as the companies have reported in a press release.

Novalab, in addition to being a reference in diabetes, also has an important weight in cardiovascular or the cyclium of women, and since its foundation in 1997 has been a company committed to the well -being of diabetic people, providing reliable, simple, quality productsproven and at reasonable costs.Among them include insulin pumps, medical instrumentation, devices or diagnostic tools.

In addition, it is consolidated as a technological company that allows new developments in the field of diabetes, as well as in the improvement of the day -to -day patients through self -control or analysis tools.Its activity is extended to the entire Spanish territory.

"Thanks to this operation, Novalab's expertise about the diabetes market and the power of the Air Liquide group come together to create a structure much more than reinforced," says Alejandro García, from Novalab Iberian, after knowing the agreement.

For his part Philippe Ogé, general director of Air Liquide Healthcare in Iberia stressed that his company is present in the diabetes market in other European countries."Our experience within the group will allow us to integrate this new activity in our subsidiary in Spain, strengthen our leadership and complete our wide care offer for the hundreds of thousands of patients we attend in our country," he said.

fer's profile photo
fer
07/14/2016 11:35 a.m.

@fer - Diabetes Tipo 1 desde 1.998 | FreeStyle Libre 3 | Ypsomed mylife YpsoPump + CamAPS FX | Sin complicaciones. Miembro del equipo de moderación del foro.
Co-Autor de Vivir con Diabetes: El poder de la comunidad online, parte de los ingresos se destinan a financiar el foro de diabetes y mantener la comunidad online activa.

  

Well, let's see if prices are encouraged and lowered !!!

Papajesus1's profile photo
Papajesus1
07/16/2016 7:33 p.m.

Padre de Jesús. Bomba insulina y dexcom g4 share. Debut con 18 meses....ya con 7 añitos...Hemo entorno a 7....y mucha lucha diaria.....ya sabéis..poco dormir y bastantes miedos....pero mi niño es feliz luego yo también.

  

That does not depend on them, they are the distributor, who orchestra everything is dexcom us.

You have almost to give thanks since Dexcom in other countries is much more expensive, if you see UK prices give you a heart attack.

The Dexcom's market goal is upper class people, not us.I spend more than 10 % of my salary in the Dexcom and it is because they do not want me as a client.

Artorias's profile photo
Artorias
07/16/2016 11:15 p.m.
No signature configured, update it from user's profile.

  

The truth is that whenever I have called Novalab, they have behaved very well.A little joke, I spend almost 300 euros in the DEXCOM (sensor, receiver, transmitter) .... then at 10% earned almost 3000 euros !!!!He signed it, hopefully 3000 will win !!!!

Papajesus1's profile photo
Papajesus1
07/18/2016 7:13 p.m.

Padre de Jesús. Bomba insulina y dexcom g4 share. Debut con 18 meses....ya con 7 añitos...Hemo entorno a 7....y mucha lucha diaria.....ya sabéis..poco dormir y bastantes miedos....pero mi niño es feliz luego yo también.

  

Join the Discussion!

To participate in this thread, please register or log in.